P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma (2022)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; SAMPAIO, VANESSA FERNANDES ARNAUD - IQ ; BENTO, CAROLINA ADRIANE - IQ ; GLASER, TALITA - IQ
- Unidade: IQ
- DOI: 10.3389/fonc.2022.966404
- Subjects: RECEPTORES; NEUROBLASTOMA; RESISTÊNCIA MICROBIANA ÀS DROGAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Oncology
- ISSN: 2234-943X
- Volume/Número/Paginação/Ano: v. 12, p. 1-19 art. 966404, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SAMPAIO, Vanessa Fernandes Arnaud et al. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, v. 12, p. 1-19 art. 966404, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.966404. Acesso em: 29 maio 2024. -
APA
Sampaio, V. F. A., Bento, C. A., Glaser, T., Adinolfi, E., Ulrich, H., & Lameu, C. (2022). P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, 12, 1-19 art. 966404. doi:10.3389/fonc.2022.966404 -
NLM
Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fonc.2022.966404 -
Vancouver
Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 maio 29 ] Available from: https://doi.org/10.3389/fonc.2022.966404 - Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms
- Calcium signalling: a common target in neurological disorders and neurogenesis
- Complex diseases demand novel treatment strategies: understanding drug combination
- Purinergic receptors in neurogenic processes
- Purinergic signaling: an overview
- Using cytometry for investigation of purinergic signaling in tumor-associated macrophages
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
- Purinergic signaling in brain physiology
- Therapeutic effects of cannabinoids and their applications in COVID-19 treatment
Informações sobre o DOI: 10.3389/fonc.2022.966404 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3097051.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
